Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Sep;30(3):510–511. doi: 10.1128/aac.30.3.510

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents.

T Lambert, F Mégraud, G Gerbaud, P Courvalin
PMCID: PMC180591  PMID: 3777915

Abstract

The susceptibility of 50 strains of Campylobacter pyloridis, isolated from human gastric biopsies, to 20 antimicrobial agents representing the different families of antibiotics was tested. The pattern of susceptibility was similar to that of the C. jejuni-C. coli group except for ampicillin, cephalothin, and rifampin. The relative resistance to cefsulodin was also noted.

Full text

PDF
510

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet. 1984 Jun 16;1(8390):1348–1349. [PubMed] [Google Scholar]
  2. Corbel M. J., Ibrahim M. E., Gill K. P. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin. Vet Rec. 1984 Nov 3;115(18):465–465. doi: 10.1136/vr.115.18.465. [DOI] [PubMed] [Google Scholar]
  3. Eldridge J., Lessells A. M., Jones D. M. Antibody to spiral organisms on gastric mucosa. Lancet. 1984 Jun 2;1(8388):1237–1237. doi: 10.1016/s0140-6736(84)91716-1. [DOI] [PubMed] [Google Scholar]
  4. Elharrif Z., Mégraud F., Marchand A. M. Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother. 1985 Nov;28(5):695–697. doi: 10.1128/aac.28.5.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flores B. M., Fennell C. L., Holmes K. K., Stamm W. E. In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother. 1985 Aug;28(2):188–191. doi: 10.1128/aac.28.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goodwin C. S., Blincow E. D., Warren J. R., Waters T. E., Sanderson C. R., Easton L. Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol. 1985 Oct;38(10):1127–1131. doi: 10.1136/jcp.38.10.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaldor J., Tee W., McCarthy P., Watson J., Dwyer B. Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet. 1985 Apr 20;1(8434):921–921. doi: 10.1016/s0140-6736(85)91687-3. [DOI] [PubMed] [Google Scholar]
  8. Kasper G., Dickgiesser N. Antibiotic sensitivity of "Campylobacter pylori". Eur J Clin Microbiol. 1984 Oct;3(5):444–444. doi: 10.1007/BF02017370. [DOI] [PubMed] [Google Scholar]
  9. Lambert T., Gerbaud G., Trieu-Cuot P., Courvalin P. Structural relationship between the genes encoding 3'-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol. 1985 Sep-Oct;136B(2):135–150. doi: 10.1016/s0769-2609(85)80040-5. [DOI] [PubMed] [Google Scholar]
  10. Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985 Apr 15;142(8):436–439. doi: 10.5694/j.1326-5377.1985.tb113443.x. [DOI] [PubMed] [Google Scholar]
  11. Marshall B. J., McGechie D. B., Francis G. J., Utley P. J. Pyloric campylobacter serology. Lancet. 1984 Aug 4;2(8397):281–281. doi: 10.1016/s0140-6736(84)90318-0. [DOI] [PubMed] [Google Scholar]
  12. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  13. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  14. McNulty C. A., Dent J., Wise R. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother. 1985 Dec;28(6):837–838. doi: 10.1128/aac.28.6.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McNulty C. A., Watson D. M. Spiral bacteria of the gastric antrum. Lancet. 1984 May 12;1(8385):1068–1069. doi: 10.1016/s0140-6736(84)91469-7. [DOI] [PubMed] [Google Scholar]
  16. Megraud F., Bonnet F., Garnier M., Lamouliatte H. Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content. J Clin Microbiol. 1985 Dec;22(6):1007–1010. doi: 10.1128/jcm.22.6.1007-1010.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Skirrow M. B. Campylobacter enteritis: a "new" disease. Br Med J. 1977 Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Taylor D. E., Ng L. K., Lior H. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother. 1985 Nov;28(5):708–710. doi: 10.1128/aac.28.5.708. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES